A federal judge has ordered that the maker of Oxycontin, Purdue Pharma release records in a case in which Kentucky alleged that improper marketing of the powerful painkiller fueled a widespread addiction and death. The lawsuit alleged that Purdue misrepresented how easy it is to become addicted to Oxycontin.
Purdue Pharma, agreed in December to...
Continue reading…
Category: Pharmaceutical
Wyeth and Pfizer pay $784.6 million over drug overpricing probe whistleblowers to receive $98 million
Pharmaceutical companies Wyeth and Pfizer Inc.will pay $784.6 million to resolve allegations that Wyeth knowingly reported to the government false and fraudulent prices on two of its proton pump inhibitor (PPI) drugs, Protonix Oral and Protonix IV. Pfizer, which is headquartered in New York City, acquired New Jersey-based Wyeth in 2009, approximately three years...
Continue reading…
John Henry’s STAT news org of Boston pursues secret Purdue records on Oxycontin sales
John Henry's fledgling medical news organization, The Boston Globe Life Sciences Media, LLC d/b/a STAT, HQ'd in Boston is taking on Pursue Pharma to try to obtain thousands of documents sealed by court order, including a deposition of Dr. Richard Sackler, a Purdue board member and former company president.
In a STAT article released today,...
Continue reading…
Wyeth agrees to pay $794.6 million to settle drug pricing whistleblower case
Pfizer has reported that its subsidiary Wyeth has agreed to settle claims of the Government and whistleblowers that its methods of calculating Medicaid rebates for its drug Protonix violated law. Wyeth has agreed in principal to pay $784.6 million in order to settle.
Protonix is an acid suppressant drug. According to the Amended Complaint of...
Continue reading…
U.S. probes possible billion dollar scams on pain creams
The Justice Department is investigating half a billion dollars in possible health-care fraud linked to specialty creams used to treat pain which victimized veterans according to a report in the Wall Street Journal.
Compounding creams have recently been pitched by retired NFL quarterback Brett Favre, who promoted them to the elderly, athletes and others. It...
Continue reading…
Drugmakers shoot themselves in the feet by raising prices again!
There is an important article in today's Wall Street Journal overviewing the significant increases in prices of drugs by the pharmaceutical manufacturers--despite rising criticism by patients, doctors, politicians and healthcare payers. Some think they have priced themselves out. Others, cited in this article think the companies still have the power to continue to raise...
Continue reading…
Lumosity ordered to pay $2 million for false ads saying it protected against dementia and Alzheiemers
Lumos Labs Inc. of San Francisco, the maker of Lumosity, the "brain training" games has agreed to pay $2 million in refunds to settle federal charges that it deceived customers about the cognitive and health benefits of its apps and online products.
The Federal Trade Commission said that this, marks the highest penalty paid on...
Continue reading…
Johnson & Johnson and Purdue Pharma to pay $39.5 million to settle Oxycontin and Risperdal cases
The state of Kentucky will receive $39.5 million from the makers of OxyContin and Risperdal, resolving claims that the safety of the drugs were misrepresented to the state's residents.
The settlement agreement requires Johnson & Johnson to pay $15.5 million over failing to warn about the potential side effects of Risperdal, and Purdue Pharma LP...
Continue reading…
Endo Pharma and Qualitest Pharma pay $39 million to Uncle Sam for under strength flouride tabs for kids
The United States Attorney's Office in New York has announced a $39 million settlement against Vintage Pharmaceuticals, LLC, d/b/a QUALITEST PHARMACEUTICALS; Vintage'S corporate parent Endo Pharmaceuticals, Inc.; and seven of their corporate subsidiaries or affiliates (collectively, "QUALITEST") in a civil fraud lawsuit. This global settlement resolves federal claims under the False Claims Act, 31...
Continue reading…
Why Novartis agreed to pay a whopping $370 million to settle drug kickbacks case
Novartis Pharmaceuticals, maufacturer of Excedrin, Ritalin and other popular drugs, this week agreed to pay $370 million for paying kickbacks to pharmacies to push its drugs on patients. Federal prosecutors said Novartis' scheme involved two drugs, including Exjade, used to reduce iron overload in patients who are receiving long-term blood transfusions.
In 2007, sales of...
Continue reading…